Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio-Cord is a leading European biotechnology company specializing in the collection, processing, and cryopreservation of umbilical cord blood and tissue stem cells. Headquartered in Spain and part of the Cerba Internacional group, the company provides families with long-term storage solutions for hematopoietic and mesenchymal stem cells. Bio-Cord operates under high-quality standards, including FACT and AABB accreditations, and collaborates with clinical laboratories and hospitals across Europe. Its services are designed to preserve biological material for potential use in treating over 80 hematological diseases and in emerging regenerative medicine applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioCord.